Get the latest Science News and Discoveries

FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber


None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of FDA

FDA

Photo of Dana-Farber

Dana-Farber

Photo of Landmark

Landmark

Related news:

News photo

Using FDA addiction science, researcher asks: Do salty, high-fat foods act like drugs?

News photo

Critical Path for Parkinson’s announces milestone publication highlighting FDA support for novel biomarker to advance precision medicine strategies

News photo

In a 2023 interview, Trump’s new FDA pick laid out a vision for ‘conservative-based’ science